Immune Response: Investigating the role of vitamin D in asthma
Results in mice suggest that vitamin D reduces the symptoms of asthma by controlling an immune response that leads to inflammation of the airways.
- Department of Biology, Ashoka University, India
- Simons Ashoka Fellowship Program, Trivedi School of Biosciences, Ashoka University, India
- Koita Centre for Digital Health, Trivedi School of Biosciences, Ashoka University, India
Vitamin D deficiency has burgeoned into a major public health concern, exacerbated by dietary habits and pollution among other factors (Cui et al., 2023). While vitamin D is well known to be important for maintaining healthy bones, it has also been linked with various immune disorders, including asthma.
Supplements of vitamin D are being increasingly used to treat immune-related conditions. However, it remains unclear precisely how vitamin D is able to improve the outcome of these disorders (Scragg, 2018). Now, in eLife, Scott Weiss, Ardu Halu and co-workers – including Ayşe Kiliç as joint first author with Halu – report how vitamin D regulates an immune response that is a major contributor to asthma (Kiliç et al., 2023).
First, the team – who are based at Brigham and Women’s Hospital and Harvard Medical School, and institutes in Germany, Japan, Russia, and the United States – revisited the findings of a clinical trial called the Vitamin D Antenatal Asthma Reduction Trial (VDAART). In the trial, pregnant women who had a history of Asthma or allergies (or whose partner, the other biological parent, had a similar history), were given low or high doses of vitamin D during pregnancy. Analyses of the data found that higher vitamin D supplementation did not significantly reduce asthma in the offspring (Litonjua et al., 2016; Litonjua et al., 2020). However, a more nuanced reanalysis – which adjusted for baseline vitamin D levels to account for factors such as dietary intake – reported a reduced risk of asthma in the offspring of women who received a higher dose of vitamin D during pregnancy (Wolsk et al., 2017).
Kiliç et al. set out to find the genetic underpinnings of this protective effect, focusing their attention on chromosome 17, which contains regions strongly associated with asthma and other immune diseases (Bansal et al., 2021). Across chromosome 17 are sites where the receptor for vitamin D (known as VDR) can bind. Bioinformatic analysis revealed that some of these VDR binding sites overlapped with genetic variants associated with diseases triggered by the immune response mediated by T helper type 2 cells. These immune cells (known as Th2 for short) are a subset of white blood cells which respond proactively to invading pathogens like helminths, as well as recurrent exposures. Th2 cells act by producing inflammatory mediators as well as by modulating the activity of other cells in the immune system. They are also activated by allergens, such as mites and pollens, which can lead to allergic inflammation and disorders like asthma.
A detailed exploration of these overlapping regions suggested that VDR can trigger a cascade that regulates genes involved in the Th2 immune response. This genetic regulation could either promote or repress the Th2 response, depending on other genetic variants present in the proximity.
With a hypothesis established, the researchers tested their findings in mice which had been exposed to extracts from house dust mites to mimic the asthma phenotype (Figure 1A). They found that mice deficient in vitamin D or lacking VDRs displayed a more severe phenotype. Further experiments revealed that house dust mite exposure also caused the Th2 cells to express higher levels of VDR. When these Th2 cells were exposed to calcitriol (the active form of vitamin D), the VDRs bound to the calcitriol and migrated from the cytosol into the nucleus (Figure 1B).
Figure 1
The vitamin D receptor and its role in inflammation of the airways.
(A) To mimic the symptoms of asthma, Kiliç et al. treated a lab-grown strain of mice (known as C57Bl/6) with extracts from house dust mites (HDM). This activated a group of immune cells called T helper type 2 (Th2; green) in the lungs of the mice, leading to inflammation of their airways. (B) Kiliç et al. found that exposure to dust mites also caused the Th2 cells to produce more vitamin D receptors (purple). When the cells were treated with calcitriol, the active form of vitamin D (blue circles with black lines), the receptors migrated from the cytosol to the nucleus. Once there, the receptor can regulate the expression of genes involved in the Th2 response, including the gene Ikzf3 which suppresses the inflammatory response triggered by Th2 cells.
© 2024, BioRender Inc. Figure 1 was created using BioRender.com, and is published under a CC BY-NC-ND license. Further reproductions must adhere to the terms of this license.
These findings suggest that VDR acts like a lock waiting for its key. Access to the key (vitamin D), and migration of the VDR into the nucleus, possibly unlocks the transcriptional regulation required to modulate the immune pathways. Furthermore, VDR expression was contingent upon baseline vitamin D levels, suggesting that this vitamin has both a preventive and therapeutic potential. Kiliç et al. also found that one of the genes that VDR regulates (called Ikzf3) is a major factor in suppressing the Th2 immune response (Figure 1B). This effect is likely mediated through the STAT signaling axis, which is a critical pathway regulating inflammation (Hu et al., 2021).
The study by Kiliç, Halu, Weiss and colleagues sheds light on how vitamin D offers protective benefits against asthma. However, several pathophysiological pathways can lead to the characteristic airway inflammation associated with asthma (Moore and Bleecker, 2014). Subgroup analysis during clinical trials, along with targeted exploration of relevant biomarkers, could help identify who would benefit most from vitamin D supplements. The latest findings also underscore the importance of vitamin D in a wider sense, as the Th2 response is associated with several other chronic inflammatory diseases.
That being said, it is essential to be mindful of the broader biological role of vitamin D, as it influences both the innate and the adaptive immune system via a number of different cell types (Colotta et al., 2017). This complexity may be why scientific literature on vitamin D is marred by contradictory findings: for instance, a previous study has even shown loss of VDR to be protective against asthma (Wittke et al., 2004). However, this complexity should not deter researchers from trying to develop a deeper mechanistic understanding of vitamin D effects. Such an understanding could, in the future, enable personalized treatment strategies for individuals with immune disorders such as asthma.
References
-
Advances in asthma geneticsAdvances in Genetics 107:1–32.https://doi.org/10.1016/bs.adgen.2020.11.001
-
Modulation of inflammatory and immune responses by vitamin DJournal of Autoimmunity 85:78–97.https://doi.org/10.1016/j.jaut.2017.07.007
-
The JAK/STAT signaling pathway: from bench to clinicSignal Transduction and Targeted Therapy 6:402.https://doi.org/10.1038/s41392-021-00791-1
-
Six-year follow-up of a trial of antenatal vitamin D for asthma reductionThe New England Journal of Medicine 382:525–533.https://doi.org/10.1056/NEJMoa1906137
-
Asthma heterogeneity and severity-why is comprehensive phenotyping important?Lancet Respiratory Medicine 2:10–11.https://doi.org/10.1016/S2213-2600(13)70288-1
-
Limitations of vitamin D supplementation trials: Why observational studies will continue to help determine the role of vitamin D in healthThe Journal of Steroid Biochemistry and Molecular Biology 177:6–9.https://doi.org/10.1016/j.jsbmb.2017.06.006
-
Vitamin D receptor-deficient mice fail to develop experimental allergic asthmaJournal of Immunology 173:3432–3436.https://doi.org/10.4049/jimmunol.173.5.3432
-
Vitamin D supplementation in pregnancy, prenatal 25(OH)D levels, race, and subsequent asthma or recurrent wheeze in offspring: Secondary analyses from the Vitamin D Antenatal Asthma Reduction TrialThe Journal of Allergy and Clinical Immunology 140:1423–1429.https://doi.org/10.1016/j.jaci.2017.01.013
Article and author information
Author details
Publication history
Copyright
© 2024, Sharma and Garg
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 570
- views
-
- 52
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Immune Response: Investigating the role of vitamin D in asthma
eLife 13:e97031.
https://doi.org/10.7554/eLife.97031
Further reading
-
- Genetics and Genomics
- Immunology and Inflammation
Systemic lupus erythematosus (SLE) is an autoimmune disease, the pathophysiology and genetic basis of which are incompletely understood. Using a forward genetic screen in multiplex families with SLE, we identified an association between SLE and compound heterozygous deleterious variants in the non-receptor tyrosine kinases (NRTKs) ACK1 and BRK. Experimental blockade of ACK1 or BRK increased circulating autoantibodies in vivo in mice and exacerbated glomerular IgG deposits in an SLE mouse model. Mechanistically, NRTKs regulate activation, migration, and proliferation of immune cells. We found that the patients’ ACK1 and BRK variants impair efferocytosis, the MERTK-mediated anti-inflammatory response to apoptotic cells, in human induced pluripotent stem cell (hiPSC)-derived macrophages, which may contribute to SLE pathogenesis. Overall, our data suggest that ACK1 and BRK deficiencies are associated with human SLE and impair efferocytosis in macrophages.
-
- Genetics and Genomics
- Microbiology and Infectious Disease
The sustained success of Mycobacterium tuberculosis as a pathogen arises from its ability to persist within macrophages for extended periods and its limited responsiveness to antibiotics. Furthermore, the high incidence of resistance to the few available antituberculosis drugs is a significant concern, especially since the driving forces of the emergence of drug resistance are not clear. Drug-resistant strains of Mycobacterium tuberculosis can emerge through de novo mutations, however, mycobacterial mutation rates are low. To unravel the effects of antibiotic pressure on genome stability, we determined the genetic variability, phenotypic tolerance, DNA repair system activation, and dNTP pool upon treatment with current antibiotics using Mycobacterium smegmatis. Whole-genome sequencing revealed no significant increase in mutation rates after prolonged exposure to first-line antibiotics. However, the phenotypic fluctuation assay indicated rapid adaptation to antibiotics mediated by non-genetic factors. The upregulation of DNA repair genes, measured using qPCR, suggests that genomic integrity may be maintained through the activation of specific DNA repair pathways. Our results, indicating that antibiotic exposure does not result in de novo adaptive mutagenesis under laboratory conditions, do not lend support to the model suggesting antibiotic resistance development through drug pressure-induced microevolution.
